Characteristic analysis from excessive to deficient syndromes in hepatocarcinoma underlying miRNA array data

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Chen, Qi Long ^a,b   Lu, Yi Yu ^a   Zhang, Gui Biao ^a   Song, Ya Nan ^a   Zhou, Qian Mei ^a   Zhang, Hui ^a   Zhang, Wei ^a   Tang, Xin Sheng ^b   Su, Shi Bing ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b HUANGSHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893738493     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/324636     Document Type: Article

References (27)

1. Yuen M.-F., Hou J.-L., Chutaputti A., Hepatocellular carcinoma in the Asia pacific region. Journal of Gastroenterology and Hepatology 2009 24 3 346 353 2-s2.0-63049111543 10.1111/j.1440-1746.2009.05784.x
2. Feng G.-S., Conflicting roles of molecules in hepatocarcinogenesis: paradigm or paradox. Cancer Cell 2012 21 2 150 154 2-s2.0-84856994812 10.1016/j.ccr.2012.01.001
3. El-Serag H. B., Davila J. A., Petersen N. J., McGlynn K. A., The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Annals of Internal Medicine 2003 139 10 817 823 2-s2.0-0642303165
4. Hsu H.-C., Jeng Y.-M., Mao T.-L., Chu J.-S., Lai P.-L., Peng S.-Y., β -catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. The American Journal of Pathology 2000 157 3 763 770 2-s2.0-0034495080 (Pubitemid 32109369)
5. Jia W., Gao W.-Y., Yan Y.-Q., Wang J., Xu Z.-H., Zheng W.-J., Xiao P.-G., The rediscovery of ancient Chinese herbal formulas. Phytotherapy Research 2004 18 8 681 686 2-s2.0-4944262480 10.1002/ptr.1506 (Pubitemid 39329723)
6. Song Y. N., Sun J. J., Lu Y. Y., Therapeutic efficacy of fuzheng-huayu tablet based traditional chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trail. Evidence Based Complementary Alternative Medicine 2013 2013 8 10.1155/2013/709305 709305
7. Li R., Ma T., Gu J., Imbalanced network biomarkers for traditional Chinese medicine Syndrome in gastritis patients. Scientific Reports 2013 3, article 1543 10.1038/srep01543
8. Jiang B., Liang X., Chen Y., Integrating next-generation sequencing and traditional tongue diagnosis to determine tongue coating microbiome. Scientific Reports 2012 2, article 936 10.1038/srep00936
9. Esquela-Kerscher A., Slack F. J., Oncomirs-MicroRNAs with a role in cancer. Nature Reviews Cancer 2006 6 4 259 269 2-s2.0-33645294070 10.1038/nrc1840
10. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
11. Hou J., Lin L., Zhou W., Wang Z., Ding G., Dong Q., Qin L., Wu X., Zheng Y., Yang Y., Tian W., Zhang Q., Wang C., Zhang Q., Zhuang S.-M., Zheng L., Liang A., Tao W., Cao X., Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011 19 2 232 243 2-s2.0-79751484450 10.1016/j.ccr.2011.01.001
12. Chen G., Wang J., Cui Q., Could circulating miRNAs contribute to cancer therapy? Trends in Molecular Medicine 2013 19 2 71 73
13. Zhang H., Li Q. Y., Guo Z. Z., Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B. World Journal of Gastroenterology 2012 18 37 5188 5196
14. Zhang H., Guan Y., Lu Y. Y., Circulating miR-583 and miR-663 refer to ZHENG differentiation in chronic hepatitis B. Evidence-Based Complementary and Alternative Medicine 2013 2013 8 10.1155/2013/751341 751341
15. Chen Q. L., Lu Y. Y., Zhang G. B., Progression from excessive to deficient syndromes in chronic hepatitis B: a dynamical network analysis of miRNA array data. Evidence-Based Complementary and Alternative Medicine 2013 2013 10 10.1155/2013/945245 945245
16. Zhuang H., Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chinese Medical Journal 2007 120 24 2159 2173 2-s2.0-38349116816
17. The standards of TCM differential syndromes of viral hepatitis. Internal Medicine Hepatopathy Committee of Chinese Traditional Medicine Association, December 1991
18. Vergoulis T., Vlachos I. S., Alexiou P., TarBase 6. 0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Research 2012 40 D1 D222 D229
19. Wang X., El Naqa I. M., Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 2008 24 3 325 332 2-s2.0-38849145861 10.1093/bioinformatics/btm595 (Pubitemid 351189007)
20. Huang D. W., Sherman B. T., Lempicki R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009 4 1 44 57 2-s2.0-61449172037 10.1038/nprot.2008.211
21. Huang D. W., Sherman B. T., Lempicki R. A., Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research 2009 37 1 1 13 2-s2.0-58549112996 10.1093/nar/gkn923
22. Zheng S., Tansey W. P., Hiebert S. W., Zhao Z., Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma. BMC Medical Genomics 2011 4, article 62 2-s2.0-79961125191 10.1186/1755-8794-4-62
23. Krek A., Grün D., Poy M. N., Wolf R., Rosenberg L., Epstein E. J., MacMenamin P., Da Piedade I., Gunsalus K. C., Stoffel M., Rajewsky N., Combinatorial microRNA target predictions. Nature Genetics 2005 37 5 495 500 2-s2.0-20944450160 10.1038/ng1536 (Pubitemid 40617277)
24. Guo Y., Feng Y., Trivedi N. S., Huang S., Medusa structure of the gene regulatory network: dominance of transcription factors in cancer subtype classification. Experimental Biology and Medicine 2011 236 5 628 636 2-s2.0-79958808041 10.1258/ebm.2011.010324
25. Miller J. A., Horvath S., Geschwind D. H., Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways. Proceedings of the National Academy of Sciences of the United States of America 2010 107 28 12698 12703 2-s2.0-77955454185 10.1073/pnas.0914257107
26. He D., Liu Z. P., Honda M., Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma. Journal of Molecular Cell Biology 2012 4 3 140 152
27. Spaziani A., Alisi A., Sanna D., Balsano C., Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1. Journal of Biological Chemistry 2006 281 16 10983 10989 2-s2.0-33744958372 10.1074/jbc.M512536200 (Pubitemid 43855521)